Skip to main content
Premium Trial:

Request an Annual Quote

Castle Bio Licenses IP from Brigham and Women's Hospital for Mesothelioma Test

NEW YORK (GenomeWeb News) – Castle Biosciences has licensed the IP and technology rights from Brigham and Women's Hospital for a gene expression profiling test for mesothelioma, the company announced today.

Called DecisionDx-Mesothelioma, the test was developed and validated by the hospital and confirms differential diagnosis and predicts survival in patients undergoing standard of care surgical resection, the Friendswood, Texas-based firm said. Castle Bio added that it is completing validation of the test under College of American Pathologists accredited and CLIA-certified standard operating procedures.

The company is targeting the fourth quarter for a launch of the test.

Financial and other terms of the deal were not disclosed.

"We now have a molecular test that alone as well as in conjunction with other simple clinical parameters can help identify those patients who will most likely benefit from aggressive surgery, as well as assist with fundamental treatment planning," said Raphael Bueno, associate chief of thoracic surgery at Brigham and Women's Hospital and a professor of surgery at Harvard Medical School, who led the team in developing the test.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.